Skip to content
medical device fees Europe

What are the Fees for Selling Medical Devices in Europe?


7 mins


Selling medical devices in Europe involves multiple fee categories that vary based on your device classification and market strategy. You’ll encounter one-time expenses like CE marking certification and technical file preparation, plus recurring annual costs including European Authorized Representative fees, Notified Body surveillance audits, and post-market surveillance activities. The total investment typically ranges from several thousand to over $100,000 depending on device class and complexity.

What Fees do you Actually Pay to Sell Medical Devices in Europe?

Medical device manufacturers entering the European market face four main fee categories:

  • Regulatory certification costs – Expenses for achieving CE marking compliance, including Notified Body assessments and conformity evaluation procedures required under MDR
  • Representation services – Fees for your European Authorized Representative who serves as your regulatory contact point within the EU
  • Device registration expenses – Costs associated with EUDAMED registration and country-specific notification requirements beyond CE marking
  • Ongoing compliance activities – Recurring expenses for post-market surveillance, vigilance reporting, and maintaining regulatory conformity over time

These four categories encompass both one-time investments during market entry and recurring annual obligations throughout your product lifecycle. Your initial expenses will be concentrated in certification and technical file development, while ongoing costs ensure you maintain compliance and market access across European territories. This fee structure applies regardless of whether you’re launching a single device or managing an extensive product portfolio.
Your device classification directly impacts your total investment. Class I devices generally require lower certification fees since many can self-certify without Notified Body involvement. Class IIa, IIb, and Class III devices need Notified Body assessment, which increases costs substantially. Higher-risk devices also demand more extensive clinical evaluation and technical documentation, adding to preparation expenses.
The distinction between one-time and recurring expenses matters for budget planning. You’ll pay larger upfront costs during initial market entry, then transition to annual maintenance fees that keep your devices compliant. Understanding this structure helps you forecast both immediate investment needs and long-term operational costs across your product portfolio.

How Much does CE Marking and MDR Compliance Cost?

CE marking certification expenses vary significantly by device class:

  • Class I devices – Typically $5,000-$15,000 for technical file preparation and quality system documentation
  • Class IIa devices – Generally $15,000-$40,000 including Notified Body conformity assessment fees and more comprehensive technical documentation requirements
  • Class IIb devices – Range from $40,000-$80,000 due to increased scrutiny, more extensive clinical evaluation, and rigorous Notified Body review processes
  • Class III devices – Frequently exceed $100,000 because of stringent clinical investigation requirements, detailed risk analysis, and the most thorough Notified Body assessment procedures

These cost ranges reflect the risk-based regulatory approach under MDR, where higher-risk devices face proportionally greater scrutiny and documentation demands. The specific amount you’ll pay within each range depends on factors including device complexity, available clinical data, your quality management system maturity, and whether you engage external consultants or handle preparation internally. Manufacturers with established quality systems and comprehensive technical expertise typically spend less than those building regulatory capabilities from scratch.
Notified Body fees represent a substantial portion of your MDR compliance costs for higher-risk devices. These organizations charge for initial conformity assessment, which includes reviewing your technical documentation, evaluating your quality management system, and conducting facility audits. The specific fees depend on your chosen Notified Body, device complexity, and manufacturer size.
Technical file preparation costs vary based on whether you handle documentation internally or engage regulatory consultants. Quality management system certification to ISO 13485 adds another expense layer, typically ranging from $10,000-$30,000 depending on your organization’s size and existing quality infrastructure. Clinical evaluation expenses fluctuate widely based on available clinical data and whether you need new clinical investigations to demonstrate safety and performance under MDR requirements.

What Ongoing Fees do Medical Device Companies Pay in Europe?

Annual recurring costs form the operational baseline for maintaining European market access:

  • European Authorized Representative fees – Typically $2,000-$10,000 per year depending on portfolio size, with costs scaling based on the number of devices and complexity of regulatory support services required
  • Notified Body surveillance audits – Usually $5,000-$20,000 per audit conducted annually for most device classes to verify ongoing conformity with quality management requirements
  • Post-market surveillance activities – Continuous expenses for vigilance system maintenance, complaint handling, trend analysis, and periodic safety update reports submitted to competent authorities
  • EUDAMED registration maintenance – Ongoing effort and associated costs to keep device information, economic operator details, and certificates current as regulations evolve
  • Quality system maintenance – Internal audits, management reviews, and continuous improvement activities that keep ISO 13485 certification valid, typically 10-20% of initial certification costs annually

These recurring obligations ensure your devices remain compliant throughout their market lifecycle and demonstrate your commitment to safety and performance monitoring. The actual amounts you’ll pay depend on factors including your product portfolio complexity, the number of European markets you serve, whether you handle activities internally or outsource them, and how frequently you modify devices or introduce new products. Manufacturers with mature quality systems and established post-market surveillance infrastructure generally experience lower annual costs than those building these capabilities while simultaneously maintaining market access.

Are there Hidden Costs when Entering the European Medical Device Market?

Beyond the obvious certification and recurring fees, several less apparent expenses can significantly impact your budget:

  • Translation and labeling requirements – Professional medical translation costs $0.15-$0.30 per word, with typical instruction manuals requiring 5,000-15,000 words per language across each target market
  • Country-specific registration fees – Some European countries require national device registration or notification processes beyond CE marking, with fees ranging from $100-$2,000 per device depending on the country and device type
  • Local importation and distribution setup – Costs for establishing relationships with economic operators who handle regulatory importer responsibilities and ensure proper distribution chain compliance
  • Regulatory consulting for complex submissions – Specialist support expenses when you need expert guidance for clinical evaluation, technical documentation, or navigating unique device features that require specialized regulatory knowledge
  • Re-certification expenses – Potential costs if regulations change significantly or you modify devices in ways requiring updated conformity assessment, potentially repeating substantial portions of your initial certification investment

These hidden costs often emerge during implementation rather than initial planning, catching manufacturers off guard and straining budgets. Translation expenses alone can add $10,000-$50,000 for a single device across multiple languages, while country-specific requirements create an administrative burden that scales with each new market you enter. Manufacturers who anticipate these expenses during initial budget planning avoid cash flow disruptions and can negotiate better rates with service providers by engaging them earlier in the process rather than scrambling to meet unexpected obligations.

How MedEnvoy Global Helps with European Medical Device Market Access

MedEnvoy Global provides comprehensive regulatory support that simplifies the complex fee landscape for medical device manufacturers entering European markets. Our consolidated approach addresses the key cost challenges outlined in this article:

  • Transparent pricing structure – Clear, upfront cost estimates for European Authorized Representative services, country-specific registrations, and ongoing compliance activities across your entire portfolio
  • Multi-country representation – Single-point coordination for regulatory requirements across multiple European territories, eliminating the need to manage separate representatives in each market
  • Post-market surveillance support – Streamlined vigilance reporting, complaint handling, and regulatory communication that reduces your ongoing compliance burden and associated costs
  • Strategic planning guidance – Expert consultation on optimizing your market entry sequence and budget allocation to maximize return on investment while maintaining full regulatory compliance

By partnering with MedEnvoy Global, you gain a dedicated regulatory team that handles the administrative complexity of European market access, allowing you to focus resources on product development and commercial growth. Contact us today to discuss how we can create a customized regulatory strategy that fits your budget and market objectives.

Related Articles